Airway inflammation and mannitol challenge test in COPD
2011

Mannitol Challenge Test and Airway Inflammation in COPD

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Selma B de Nijs, Niki Fens, Rene Lutter, Erica Dijkers, Frans H Krouwels, Barbara S Smids-Dierdorp, Reindert P van Steenwijk, Peter J Sterk

Primary Institution: Academic Medical Centre and University of Amsterdam

Hypothesis

AHR to inhaled mannitol captures eosinophilia in induced sputum in COPD.

Conclusion

Mannitol hyperresponsiveness is associated with biomarkers of airway inflammation in mild-moderate COPD.

Supporting Evidence

  • There was a positive correlation between RDR to mannitol and eosinophil numbers.
  • Significant correlations were found between RDR and levels of ECP, IL-8, and MPO in sputum.
  • ROC-curves showed 60% sensitivity and 100% specificity of RDR for >2.5% eosinophils in mannitol-induced sputum.

Takeaway

The study found that a test using mannitol can help identify inflammation in the lungs of COPD patients, which can guide their treatment.

Methodology

The study involved 28 patients with mild-moderate COPD who underwent mannitol challenge and sputum collection to assess airway inflammation.

Potential Biases

Potential inclusion of patients with undiagnosed asthma despite exclusion criteria.

Limitations

Some patients could not provide adequate sputum samples, and the study may not generalize to COPD patients on inhaled corticosteroids.

Participant Demographics

28 patients, mean age 58 years, 23 males and 5 females, with a smoking history of 40 pack-years.

Statistical Information

P-Value

0.001

Confidence Interval

95% CI, 33.6 to 97.5%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-12-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication